Summary
This business is focused on developing a new class of epigenetic medicines aimed at revolutionizing the treatment of genetically driven diseases. By leveraging the natural mechanisms of gene regulation, they aim to create genomic therapeutics that provide precise control over gene expression without altering the DNA sequence itself. Their approach is based on advanced research in the field of genomic medicine, promising durable and specific treatments.
35.185.14.80 |
10 us-smtp-inbound-1.mimecast.com. |
9 us-smtp-inbound-2.mimecast.com. |
ns35.domaincontrol.com. |
ns36.domaincontrol.com. |
c13474ba6c |
zoom_verify_d137iqnld172njvdqwuwyv |
zoom_verify_pdxcim8up3iq9mkintenmb |
apple-domain-verification=uretgalxiuflsjvz |
asv=2b9785971bccea941a43c89f1975a54b |
atlassian-domain-verification=mwwulf85ktrlhcn34wwmezqojpjikajcdyvryjkk5sc2zky3mou0ingnzj7yoa2q |
docusign=8b5b187d-4352-4469-9f11-fe6955898f11 |
v=spf1 include:us._netblocks.mimecast.com include:spf.protection.outlook.com ~all |